The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets
Abstract
In recent years, the use of the last observation carried forward (LOCF) approach in imputing missing data in clinical trials has been greatly criticized, and several likelihood-based modeling approaches are proposed to analyze such incomplete data. One of the proposed likelihood-based methods is the Mixed-Effect Model Repeated Measure (MMRM) model. To compare the performance of LOCF and MMRM approaches in analyzing incomplete data, two extensive simulation studies are conducted, and the empirical bias and Type I error rates associated with estimators and tests of treatment effects under three missing data paradigms are evaluated. The simulation studies demonstrate that LOCF analysis can lead to substantial biases in estimators of treatment effects and can greatly inflate Type I error rates of the statistical tests, whereas MMRM analysis on the available data leads to estimators with comparatively small bias, and controls Type I error rates at a nominal level in the presence of missing completely at random (MCAR) or missing at random (MAR) and some possibility of missing not at random (MNAR) data. In a sensitivity analysis of 48 clinical trial datasets obtained from 25 New Drug Applications (NDA) submissions of neurological and psychiatric drug products, MMRM analysis appears to be a superior approach in controlling Type I error rates and minimizing biases, as compared to LOCF ANCOVA analysis. In the exploratory analyses of the datasets, no clear evidence of the presence of MNAR missingness is found.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Missing data were managed using LMM, which is based on all observed data and accounts for data missing at random [108-110].”
Citations
Cites
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,385
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Linear Mixed Models for Longitudinal Data
Verbeke, G. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4612-2294-1_3 · Cited by 3,506
Linear Mixed Models for Longitudinal Data
Molenberghs, G., & Verbeke, G. N. (2000) · Springer series in statistics · doi:10.1007/978-1-4419-0300-6 · Cited by 2,681
Modeling the Drop-Out Mechanism in Repeated-Measures Studies
Little, R. J. A. (1995) · Journal of the American Statistical Association · doi:10.1080/01621459.1995.10476615 · Cited by 1,522
Informative Drop-Out in Longitudinal Data Analysis
Diggle, P. J., & Kenward, M. G. (1994) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.2307/2986113 · Cited by 1,472
(2004) · Choice Reviews Online · doi:10.5860/choice.42-2265 · Cited by 1,385
Cited by
Sorted by citations
Items 201–300 of 301
Monticone, M., AMBROSINI, E., Portoghese, I., & ROCCA, B. (2021) · European Journal of Physical and Rehabilitation Medicine · doi:10.23736/s1973-9087.21.06696-x · Cited by 11
RetractedBraccini, J. M., O‘Neill, M. F., Campbell, A. B., Leigh, G. M., & Courtney, A. J. (2012) · Canadian Journal of Fisheries and Aquatic Sciences · doi:10.1139/f2012-023 · Cited by 12
Feng, W., Vasquez, G., Suri, M. F. K., Lakshminarayan, K., & Qureshi, A. I. (2010) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2010.01.003 · Cited by 12
Monticone, M., Portoghese, I., Cazzaniga, D., Liquori, V., Marongiu, G., Capone, A., Campagna, M., & Zatti, G. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04140-9 · Cited by 13
García‐Hernandez, A., Pérez, T., Pardo, M. D. C., & Rizopoulos, D. (2020) · Pharmaceutical Statistics · doi:10.1002/pst.2045 · Cited by 11
On assessing potential efficacy for vortioxetine in generalized anxiety disorder
Baldwin, D. S., & Nutt, D. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.018 · Cited by 11
The quality of reporting of phase II and III trials for new antipsychotics: a systematic review
Patel, M. X., Collins, S., Hellier, J. M., Bhatia, G., & Murray, R. M. (2014) · Psychological Medicine · doi:10.1017/s0033291714001214 · Cited by 9
Tang, Y. (2016) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2016.1167075 · Cited by 9
Vortioxetine in the treatment of major depressive disorder
Baldwin, D. S., & Hanumanthaiah, V. B. (2015) · Future Neurology · doi:10.2217/fnl.14.69 · Cited by 9
An Alternative Implementation of Reference-Based Controlled Imputation Procedures
Lu, K. (2020) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2020.1796781 · Cited by 8
Monteiro, F., Pereira, M., Canavarro, M. C., & Fonseca, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.701107 · Cited by 15
Setyawan, J., Yang, H., Cheng, D., Cai, X., Signorovitch, J., Xie, J., & Erder, M. H. (2015) · Value in Health · doi:10.1016/j.jval.2015.06.005 · Cited by 8
Kozielska, M., Reddy, V. P., Johnson, M. G., Ridder, F. D., Vermeulen, A., Liu, J., Groothuis, G. M. M., Danhof, M., & Proost, J. H. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.022 · Cited by 8
Short notes on maximum likelihood inference for control‐based pattern‐mixture models
Tang, Y. (2015) · Pharmaceutical Statistics · doi:10.1002/pst.1698 · Cited by 8
Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials
Kennedy, R., Cutter, G., Wang, G., & Schneider, L. S. S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150847 · Cited by 8
Yan, M.-Q., Zhou, L., Zhao, C., Shi, C., & Ou, C. (2025) · Health and Quality of Life Outcomes · doi:10.1186/s12955-025-02364-0 · Cited by 9
Monticone, M., Vullo, S. S., Lecca, L. I., Meloni, F., Portoghese, I., & Campagna, M. (2022) · Trials · doi:10.1186/s13063-022-06340-7 · Cited by 7
A noniterative sample size procedure for tests based on t distributions
Tang, Y. (2018) · Statistics in Medicine · doi:10.1002/sim.7807 · Cited by 7
Tiwari, V., Lee, J., Sharma, G. D., Kang, Y. G., & Kim, T. K. (2019) · Journal of Orthopaedics and Traumatology · doi:10.1186/s10195-019-0520-8 · Cited by 7
Bayesian modeling and inference for clinical trials with partial retrieved data following dropout
Chen, Q., Chen, M., Ohlssen, D. I., & Ibrahim, J. G. (2013) · Statistics in Medicine · doi:10.1002/sim.5812 · Cited by 6
McIntyre, R. S., Sundararajan, K., Behl, S., Hefting, N., Jin, N., Brewer, C., Hobart, M., & Thase, M. E. (2024) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.32 · Cited by 7
Spinelli, M. G., Endicott, J., & Goetz, R. R. (2015) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000462604.79606.4e · Cited by 6
Emergency Hospital Care for Exacerbation of COPD: Is Inhaled Maintenance Therapy Modified?
Pomares, X., Montón, C., Baré, M., Pont, M., Estirado, C., Gea, J., Quintana, J. M., Vidal, S., Santiago, A., & the IRYSS-COPD Appropriateness study group (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1043517 · Cited by 6
Lu, K. (2011) · Statistics in Medicine · doi:10.1002/sim.4415 · Cited by 6
Tang, Y. (2017) · Statistics in Medicine · doi:10.1002/sim.7270 · Cited by 6
Maruo, K., Ishii, R., Yamaguchi, Y., Doi, M., & Gosho, M. (2020) · Statistics in Medicine · doi:10.1002/sim.8474 · Cited by 6
Reproducibility Challenges for Biomarker Detection with Uncertain But Informative Experimental Data
Zhuang, W. V., Camacho, L., Silva, C. S., & Hong, H. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0599 · Cited by 6
Monticone, M., Ambrosini, E., Rocca, B., Cazzaniga, D., Liquori, V., Lovi, A., & Brayda‐Bruno, M. (2020) · Disability and Rehabilitation · doi:10.1080/09638288.2020.1863480 · Cited by 6
RetractedKeutzer, L., Mockeliūnas, L., Sturkenboom, M. G. G., Bolhuis, M. S., Akkerman, O. W., & Simonsson, U. S. H. (2023) · Pharmaceuticals · doi:10.3390/ph16111575 · Cited by 5
Dinh, P. V. (2013) · Pharmaceutical Statistics · doi:10.1002/pst.1579 · Cited by 5
Comparison of Precision and Accuracy of Five Methods to Analyse Total Score Data
Wellhagen, G. J., Karlsson, M. O., & Kjellsson, M. C. (2020) · The AAPS Journal · doi:10.1208/s12248-020-00546-w · Cited by 5
Holtz, L. R., Kroenke, K., Gao, S., Hickman, S. E., Torke, A. M., Johnson, N. M., Pemberton, A., Vrobel, A., Pan, M., & Sachs, G. A. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107217 · Cited by 5
Evaluation of Overall Treatment Effect in MMRM
Song, T., Dong, Q., Sankoh, A. J., & Molenberghs, G. (2013) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.834918 · Cited by 5
Matsusaki, A., Kaneko, M., & Narukawa, M. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0661-1 · Cited by 5
Dose-Response Mixed Models for Repeated Measures – a New Method for Assessment of Dose-Response
Wellhagen, G. J., Hamrén, B., Kjellsson, M. C., & Åstrand, M. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02882-0 · Cited by 5
Urao, Y., Yoshida, M., Sato, Y., & Shimizu, E. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04326-y · Cited by 12
Calkins, A., Gudin, J., Gidal, B. E., Jaros, M. J., Kim, R., & Shang, G. Y. (2016) · Pain Medicine · doi:10.1093/pm/pnv072 · Cited by 5
Wang, S. (2009) · Statistics in Biopharmaceutical Research · doi:10.1198/sbr.2009.0066 · Cited by 5
Challenges in the development of treatment guidelines for bipolar disorder
Fountoulakis, K. Ν., Fountoulakis, N. K., & Antoniadis, D. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1564004 · Cited by 4
Carona, C., Pereira, M., Araújo-Pedrosa, A., Monteiro, F., Canavarro, M. C., & Fonseca, A. (2023) · Behavior Therapy · doi:10.1016/j.beth.2023.11.001 · Cited by 5
Cristea, I. A., Gentili, C., Pietrini, P., & Cuijpers, P. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171654 · Cited by 4
Debray, T. P. A., Simoneau, G., Copetti, M., Platt, R. W., Shen, C., Pellegrini, F., & de Moor, C. (2023) · Statistical Methods in Medical Research · doi:10.1177/09622802231172032 · Cited by 4
Arippa, F., Scribante, A., Rocca, B., & Monticone, M. (2023) · Trials · doi:10.1186/s13063-023-07778-z · Cited by 4
Wang, S., Schwartz, P. F., & Mancuso, J. P. (2025) · BMC Medical Research Methodology · doi:10.1186/s12874-025-02494-5 · Cited by 5
The efficacy of vortioxetine for the treatment of major depressive disorder
Dhir, A., & Sarvaiya, J. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.987131 · Cited by 4
Widmann, M., Apondi, B., Musau, A., Warsame, A. H., Isse, M., Mutiso, V., Veltrup, C., Schalinski, I., Ndetei, D., & Odenwald, M. (2022) · BMC Public Health · doi:10.1186/s12889-022-14681-w · Cited by 3
Which aspects of anhedonia predict response to pharmacotherapy in major depressive disorder?
Uher, R., Rizvi, S. J., Quilty, L. C., Pavlová, B., Nunes, A., Foster, J. A., Lam, R. W. M., Milev, R. V., Müller, D. J., Taylor, V., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725102894 · Cited by 3
Tang, Y. (2019) · Statistical Methods in Medical Research · doi:10.1177/0962280219865579 · Cited by 3
Palmer, R. H., Periclou, A. P., & Banerjee, P. (2010) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x10372551 · Cited by 6
Handling Missing Data in Vaccine Clinical Trials for Immunogenicity and Safety Evaluation
Li, X., Wang, W. W. B., Liu, G. F., & Chan, I. S. F. (2011) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2011.550111 · Cited by 3
Llanos‐Paez, C., Ambery, C. L., Yang, S., Tabberer, M. M., Beerahee, M., Plan, E. L., & Karlsson, M. O. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00600-1 · Cited by 3
Methods to improve the efficiency of confirmatory clinical trials
Boessen, R. (2013) · Utrecht University Repository (Utrecht University) · Cited by 3
Randomized Controlled Trials and the Efficacy of Psychotropic Medications
Dunlop, B. W., & Ribeiro, C. M. D. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_4 · Cited by 2
Aripiprazole versus brexpiprazole for people with schizophrenia
Martínez-Vélez, N. A., Escamilla-Orozco, R. I., Flores-Medina, Y., Saracco-Álvarez, R. A., Rosel-Vales, M., Salas, I. A., & Hernández, G. Y. S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014670 · Cited by 2
Rabinowitz, J., Werbeloff, N., Caers, I., Mandel, F. S., Jaeger, J., Stauffer, V. L., Ménard, F., Kinon, B. J., & Kapur, S. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.010 · Cited by 2
Helms, R. W., Reece, L. H., Helms, R. W., & Helms, M. W. (2011) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2011.550097 · Cited by 2
Gosho, M., Maruo, K., Ishii, R., & Hirakawa, A. (2016) · Statistical Methods in Medical Research · doi:10.1177/0962280216677879 · Cited by 2
A Guide to Planning for Missing Data
O’Kelly, M., & Ratitch, B. (2014) · doi:10.1002/9781118762516.ch4 · Cited by 2
A Simple Correction to Completer Analyses and Improvement on Baseline Observation Carried Forward
Petroff, D. (2017) · Biometrics · doi:10.1111/biom.12661 · Cited by 2
Gosho, M., & Maruo, K. (2017) · Ouyou toukeigaku · doi:10.5023/jappstat.46.53 · Cited by 1
Parental Early Life Maltreatment and Related Experiences in Treatment of Youth Anxiety Disorder
Bertelsen, T. B., Haugland, B. S. M., Wergeland, G. J., & Håland, Å. T. (2023) · Child Psychiatry & Human Development · doi:10.1007/s10578-023-01520-1 · Cited by 1
Maruo, K., Ishii, R., Yamaguchi, Y., Ohigashi, T., & Gosho, M. (2024) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2024.2420632 · Cited by 1
Yang, L., Llanos‐Paez, C., Yang, S., Ambery, C. L., Berges, A., Kjellsson, M. C., & Karlsson, M. O. (2025) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.70059 · Cited by 1
RAGAZZO, F., Ferrari, S., EPIFANI, B., SIMIONATO, S., Arippa, F., Rocca, B., & Monticone, M. (2026) · Minerva Orthopedics · doi:10.23736/s2784-8469.26.04682-1 · Cited by 1
Hakala, M., Zschiesche, E., Hala, P., & Kuhlmann, I. (2026) · Veterinary Dermatology · doi:10.1111/vde.70121 · Cited by 1
Bunouf, P., Grouin, J., Molenberghs, G., & Koch, G. G. (2011) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/j.1467-985x.2011.01014.x · Cited by 1
Contributions of Robert T. O’Neill to the Evolution of Regulatory Statistical Science
Anello, C., & Junod, S. W. (2013) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2013.818817 · Cited by 1
Joint modeling of missing and mismeasured measurements for computing radiotherapy margins
Bhattacharjee, A., Jose, J., Vishwakarma, G. K., & Kumar, R. (2017) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2016.12.003 · Cited by 1
Randomized Controlled Trials and the Efficacy of Psychotropic Medications
Dunlop, B. W., & Ribeiro, C. M. D. F. (2019) · Springer eBooks · doi:10.1007/978-3-319-56015-1_4-1 · Cited by 2
How to implement the ‘one patient, one vote’ principle under the framework of estimand
Ting, N. (2023) · Statistical Theory and Related Fields · doi:10.1080/24754269.2023.2164943 · Cited by 1
Braccini, J. M., O‘Neill, M. F., Campbell, A. B., Leigh, G. M., & Courtney, A. J. (2011) · Queensland Department of Agriculture and Fisheries archive of scientific and research publications (Queensland Department of Agriculture and Fisheries) · Cited by 1
Mosquera, L., Karim, M. E., & Hossain, M. B. (2023) · Journal of Statistical Research · doi:10.3329/jsr.v56i2.67467 · Cited by 2
Grandemange, E., Fournel, S., & Woehrlé, F. (2014) · Journal of Small Animal Practice · doi:10.1111/jsap.12302_2 · Cited by 1
Campbell, G., Li, H., Pennello, G. A., & Yue, L. Q. (2018) · Wiley eBooks · doi:10.1002/9781118445112.stat04944.pub2 · Cited by 1
Ting, N., Sha, N., Schumacher, H., & Ley, L. (2014) · Open Access Medical Statistics · doi:10.2147/oams.s50966
Stiger, T. R., & Banerjee, A. (2013) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.834910
Mixed model variance adjustments when missing values are multiply imputed
Chakraborty, H. (2013) · Journal of Medical Statistics and Informatics · doi:10.7243/2053-7662-1-2
Response to Marks, Abramowitz, and Spielmans Letter to the Editor
Tran, P., Skolnick, P., Czobor, P., Huang, N., Bradshaw, M. H., McKinney, A. A., & D, M. F. M. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.02.001
Odenstedt, J. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Handling of Missing Data in Clinical Trials: From the Industry Viewpoint
Togo, O. (2014) · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · doi:10.3999/jscpt.45.135
Statistics issues relevant to CNS drug development
Mallinckrodt, C. H., Prucka, W. R., & Molenberghs, G. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977640.008
Analysis of Health-Related Quality of Life and Patient-Reported Outcomes in Oncology
King‐Kallimanis, B. L., Jensen, R. E., Pinheiro, L. C., & Fairclough, D. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-71324-3_20
Strategic Shift of Statistical Review on Data Quality Assessment for New Drug Applications in China
Wang, J., Wang, G., Li, M., Han, J., Zeng, X., Pan, J., & Jin-bo, Y. (2018) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479018778528
Variation in analytic transparency in recent efficacy studies of antidepressant medication
Vannoy, S. D., Brodt, M., Cosgrove, L., & Shaughnessy, A. F. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2018-110947
Zhao, Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/c5ef-vy89
Gnang, J. S., Kim, Y., Ren, Y., Travis, J., & Kim, Y. (2020) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-020-00168-6
O’Kelly, M., & Ratitch, B. (2014) · doi:10.1002/9781118762516.biblio
Tsuchikawa, M., & Sakamaki, K. (2022) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2022.2050289
Shaibani, A. I., Fares, S., Sélam, J.-L., Arslanian, A., Simpson, J., Sen, D. L., & Bongardt, S. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.03.001
Chauhan, A., Eriksson, G., Storrar, W., Brown, T., Peterson, S., Radner, F., D'Cruz, L. G., Miller, P., & Bjermer, L. H. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02205-6
Mitroiu, M., Teerenstra, S., Rengerink, K. O., Pétavy, F., & Roes, K. C. B. (2024) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2024.2369266
Biney, F. O., Marwitz, J. H., Zhang, Y., Kennedy, R., Hammond, F. M., & Abbasi, K. (2025) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2025.03.035
Futility Analyses for the MCP ‐Mod Methodology Based on Longitudinal Models
Bornkamp, B., Zhou, J., Xi, D., & Cao, W. (2025) · Statistics in Medicine · doi:10.1002/sim.70274
A study on the robustness of linear mixed effects models to violation of error assumptions
Jeong, J., & Lee, J. W. (2025) · Korean Journal of Applied Statistics · doi:10.5351/kjas.2025.38.5.637
Gates, M. W., Metz, M. A., & Schauff, M. E. (2006) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.173298
Arippa, F., Scribante, A., Rocca, B., & Monticone, M. (2023) · Figshare · doi:10.6084/m9.figshare.24564165
Koh, S.-H., Kwon, H. S., Choi, S. H., Jeong, J. H., Na, H. R., Lee, C. N., Yang, Y., Lee, A. Y., Lee, J.-H., Park, K. W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14329456
Koh, S.-H., Kwon, H. S., Choi, S. H., Jeong, J. H., Na, H. R., Lee, C. N., Yang, Y., Lee, A. Y., Lee, J.-H., Park, K. W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14329453
Many-to-one comparisons with general linear model in the presence of missing observations
Jiang, W., Lin, X., & Pan, S. (2026) · Research in Statistics · doi:10.1080/27684520.2026.2702166
Matos, M. R. A., Salgado, O. F. S., Mendez, Y. A., del Pozo, S., & Casanovas, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15166383
Metadata
- Authors
- Siddiqui, O., Hung, H. M. J., & O'Neill, R.
- Affiliations
- United States Food and Drug Administration (US)
- a Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland, USA
- Corresponding author
- Siddiqui, Ohidul
- ORCID
- Hung, H. M. James
- Venue
- Journal of Biopharmaceutical Statistics
- Publisher
- Informa UK Limited
- Published
- 2009-02-12
- Volume
- 19
- Issue
- 2
- Pages
- 227-246
- ISSN
- 1054-3406 (ISSN-L)
- 1520-5711
- OpenAlex
- W2129152730
- Cited by
- 301
- References
- 32
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 7 · 2023: 15 · 2022: 10 · 2021: 12 · 2020: 18 · 2019: 14 · 2018: 16 · 2017: 23 · 2016: 22 · 2015: 25 · 2014: 32 · 2013: 31 · 2012: 20
- FWCI
- 17.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Biopharmaceutical Statistics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- last observation carried forward, missing data imputation, clinical trials, type I error rate, estimation bias, missing completely at random, missing at random, missing not at random, new drug applications, neurological drugs, psychiatric medication, covariance analysis
- MeSH terms
- Algorithms, Clinical Trials as Topic, Computer Simulation, Data Interpretation, Statistical, Humans, Longitudinal Studies, Psychotropic Drugs, Regression Analysis, United States, United States Food and Drug Administration, Reproducibility of Results, Models, Statistical, Bias, Likelihood Functions, Least-Squares Analysis, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review